Ma Songjiang 13D and 13G filings for Gyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-06 08:31 am Purchase |
2024-09-06 | 13D | Gyre Therapeutics, Inc. GYRE |
Ma Songjiang | 7,456,847 7.620% |
7,456,847 (New Position) |
Filing |